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1. Summary
Although protein S (PROS1) and growth arrest-specific protein 6 (GAS6) proteins
are homologous with a high degree of structural similarity, they are functionally
different. The objectives of this study were to identify the evolutionary origins
from which these functional differences arose. Bioinformatics methods were
used to estimate the evolutionary divergence time and to detect the amino acid
residues under functional divergence between GAS6 and PROS1. The properties
of these residues were analysed in the light of their three-dimensional structures,
such as their stability effects, the identification of electrostatic patches and the
identification potential protein–protein interaction. The divergence between
GAS6 and PROS1 probably occurred during the whole-genome duplications in
vertebrates. A total of 78 amino acid sites were identified to be under functional
divergence. One of these sites, Asn463, is involved in N-glycosylation in GAS6,
but is mutated in PROS1, preventing this post-translational modification. Sites
experiencing functional divergence tend to express a greater diversity of stabiliz-
ing/destabilizing effects than sites that do not experience such functional
divergence. Three electrostatic patches in the LG1/LG2 domains were found to
differ between GAS6 and PROS1. Finally, a surface responsible for protein–
protein interactions was identified. These results may help researchers to analyse
disease-causing mutations in the light of evolutionary and structural constraints,
and link genetic pathology to clinical phenotypes.
2. Introduction
Growth arrest-specific protein 6 (GAS6, MIM# 600441) and protein S (PROS1,
MIM# 176880) are homologous vitamin K-dependent proteins [1]. Whereas
GAS6 is the main ligand for receptor tyrosine kinase Tyro3, Axl and Mer
(TAM), several lines of evidence have shown that PROS1 also interacts with
Tyro3 and Mer, but with a high degree of species specificity [2]. No interactions
between PROS1 and Axl have been reported. PROS1 functions as a cofactor for
activated protein C (APC) in the proteolytic degradation of activated coagu-
lation factors Va (FVa) and VIIIa (FVIIIa) [3,4]. Recently, PROS1 has also
been identified to function as a cofactor for tissue factor pathway inhibitor
(TFPI), accelerating the inhibition of activated factor Xa (FXa) [5]. GAS6 and
PROS1 have been associated with a wide variety of conditions and disorders,
including thrombosis [6,7], systemic lupus erythematus [8,9], kidney disorders
[10,11], sepsis [12,13], cancer [14,15], pregnancy [16], infections such as human
immunodeficiency virus [17] and during the use of oral contraceptives [18].
Interestingly, both proteins exhibit different expression profiles. Contrary to
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PROS1, GAS6 is not expressed in the liver, and its concen-
tration in human plasma is almost 1500-fold less than that
of PROS1 (0.22 versus 346 nmol l21) [19,20].
GAS6 and PROS1 show a high degree of similarity, both in
module organization and at the amino acid level. GAS6 is 721
amino acids long (the isoform 2 has a length of 678 amino
acids) and PROS1 is 676 amino acids long. Both are multi-
modular proteins with an N-terminal region containing the
g-carboxyglutamic acid (GLA) domain, which is formed after
the post-translational modification of glutamic acid [21]. The
GLA domain is followed by a thumb loop, four sequentially
arranged epidermal growth factor-like (EGF) domains and
two laminin G (LG) domains that make up the sex hormone-
binding globulin (SHBG). The SHBG-domain of GAS6 is
required for its interactionwith the Axl receptor [22]. The bind-
ing site for complement component C4-binding protein (C4BP)
is contained in both LG domains within the SHBG-domain of
PROS1 [23–32], whereas the LG domains of PROS1, and in
particular LG2, were shown to be indispensable for expression
of the anticoagulant activities in the APC-catalysed inacti-
vation of FVa and FVIIIa [33,34]. The LG2 domain of PROS1
also seems to contain a binding site for FVa [35]. Recently,
the LG1 domain of PROS1 was shown to be essential for
binding and enhancement of TFPI [36].
In plasma, approximately 60% of the total amount of
PROS1 is bound to C4BP, while the remaining 40% circulates
free and functions as a cofactor for APC. It has recently been
suggested that residues within the GLA and EGF1 domains
of PROS1 act cooperatively for its APC cofactor function [37].
The PROS1-binding site on C4BP is contained within the first
short consensus repeat (SCR) of its beta-chain [38–41]. SCR2
contributes to the interaction of SCR1 with PROS1 [42–44].
AsGAS6 andPROS1 homologues share a commonancestor
and have retained overall structural similarities, why are they
functionally different? For example, both GAS6 and PROS1
are post-translationally modified through N-linked glycosyla-
tion (addition of a N-acetyl-D-glucosamine to an asparagine),
but at different positions, suggesting a potential shift in func-
tion. The availability of whole-genome data has enabled
scientists to address such questions through bioinformatic
approaches. GAS6 and PROS1 are paralogous genes that
were separated during a duplication event, probably during
the two rounds of whole-genome duplication at the beginning
of vertebrate evolution. Gene duplication followed by specia-
tion provides opportunities for the creation of novel genetic
content [45–47]. The replacement (or substitution) rate of
amino acids in proteins can be accelerated or decelerated,
depending on the functional constraints and the selective
advantage of these new mutations [48]. Advantageous
mutations become ultimately fixed in the population. Such
functional divergence at the level of amino acids between
homologous genes can be classified into two types (Type I or
Type II) of functional divergence [49,50]. Type I is characterized
by amino acid patterns that are highly conserved in one group
of sequences (clade) but highly variable in the other. On the
other hand, Type II represents amino acid patterns that are
highly conserved in one group of sequences (clade) and also
conserved in the other group of sequences, but for a different
amino acid. Sites detected under either Type I or Type II of
functional divergence could explain the functional differences
between groups of sequences (orthologues or paralogues) [51].
In this context,weusedan evolutionaryapproach to (i) ident-
ify the gene duplication and the subsequent evolution that lead
to the formation of GAS6 and PROS1, (ii) identify amino acid
regions that are responsible for functional divergence between
GAS6 and PROS1, and (iii) elucidate the structural impact of
these regions on the GAS6 and PROS1 protein structures.
3. Material and methods
3.1. Data collection
Homologous protein sequences were collected by running
BlastP searches of the human PROS1 sequence (Uniprot ID:
P07225) against the UniProtKB/Swiss-Prot database (www.
uniprot.org). These retrieved sequences were aligned using
the L-INS-i algorithm from MAFFT (v. 7.113b), a multiple
sequence alignment (MSA) program [52]. The dataset is
composed of 32 sequenceswith 314 sites. The graphical render-
ing of the alignment using JALVIEW 2.8 [53] is provided
as electronic supplementary material, figure S1. Pairwise
percentage identities were calculated using CLUSTALX.
3.2. Phylogenetic analyses
Phylogenetic analyses producing trees reflecting the evol-
utionary history of this family were carried out using three
different methods: (i) a neighbour-joining (NJ) distance
matrix tree with exclusion of regions containing insertions
and deletions, and correction for multiple substitutions
with 1000 bootstrap samplings, created using the Tree
option of CLUSTALX; (ii) a maximum-likelihood (ML) analysis
with 100 bootstrap samplings using the JTT evolutionary sub-
stitution model with gamma rate distribution carried using
with the program PHYML [54]; and finally, (iii) a phylogenetic
tree inferred by Bayesian analysis using the programMRBAYES
v. 3.2 [55]. The model using the JTT substitution matrix and a
gamma rate distribution with four substitution rate categories
was the best-fitting model to our data. To estimate Bayesian
posterior probabilities, Markov chain Monte Carlo (MCMC)
chains were run for 100 000 generations and sampled every
100 generations (burn-in: 25%). The resulting tree was
rooted using mid-point rooting (figure 1; electronic sup-
plementary material, table S1). Strict and relaxed molecular
clock models were applied to the same dataset running,
respectively, 100 000 and 400 000 generations (MRBAYES).
The molecular clock was time calibrated as follows: from
the divergence times of various pairs of taxa obtained from
the TimeTree web resource (http://www.timetree.org/) [56]
the clock rates, in substitutions per site per Myr, were esti-
mated and an average clock rate was calculated. Best results
were obtained with the relaxed clock model.
3.3. Identification of amino acids under functional
divergence
For the identification of functional divergence, the original data-
setwas limited toonlyGAS6andPROS1sequences.This resulted
ina total of 30 sequences, fromaGAS6andaPROS1cladewith15
sequences each. Amino acid sites under potential functional
divergence have been identified by using three methods from
two different packages: BADASP [57] and FUNDI [58].
BADASP is a package to detect both Type I and Type II of
functional divergence [57]. A score is given to each position on
themultiple alignment on the probability to be associatedwith
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Type II and/or Type I, according to a threshold. A previous
simulations study estimated this threshold to be 3.5 [59]. In
this previous study, we generated alignments composed of
random sites, under a nearly neutral process. We then com-
puted the BADASP score for each site and defined the 99th
percentile based on the distribution of these scores. This per-
centile corresponds to a score of 3.5, which we used as our
threshold. It means that we tolerate 1% of false positive [59].
Type I sites are further divided into Type Ia (residues con-
served in PROS1 and divergent in GAS6) and Type Ib
(residues divergent in PROS1 and conserved in GAS6; table 1).
FUNDI aims to detect sites under functional divergence
[58], independent of whether they belong to Type I or Type
II of functional divergence. A stringent 95% threshold of pos-
terior probability was used. FUNDI requires a MSA without
gaps (insertion or deletion). As some of the sequences con-
tained deletions or had ambiguous residues (annotated
with multiple ‘X’), 30 different MSAs were generated by
removing one sequence at a time, and the analyses were
performed on all these alignments. This ensured a greater
coverage than focusing on the whole alignment.
BADASP and FUNDI were applied to all these alignments
and every detected site was retained.
3.4. Identification of codons under positive selection
A change in amino acid can promote a functional change
that can be ultimately adaptive. This new adaptive change
will then be retained by positive Darwinian selection. The
detection of such positive selection at the residue level in
protein can be inferred by the estimation of the number of
non-synonymous (dN) substitutions, which change the
coded amino acid, and the number synonymous (dS) substi-
tutions, which do not change the coded amino acid. A dN/
dS ratio can be computed to estimate the selective pressure
acting on that gene, and a ratio . 1 is an indicator of posi-
tive selection, while a ratio , 1 is an indicator of negative
(purifying) selection. A dN/dS ratio close to 1 indicates
that the gene is evolving neutrally. A statistical branch-site
model that tends to identify positive selection that hap-
pened on a subset of sites (codons) in a specific lineage
(branch) is implemented in the CODEML/PAML package
[60,61]. Positive selection on a specific branch is then ident-
ified by a likelihood-ratio test (LRT) based on a null-model
that does not allow positive selection (only neutral and
negative selection) versus a model that allows positive
selection (and neutral and negative selection). When the
LRT is significant, after correction for false-discovery rate,
codons that contribute to this positive selection can be
identified by a Bayes empirical Bayes (BEB) test. Sites can
be classified under relax and strict thresholds of BEB
score. 0.95 and BEB score . 0.99, respectively.
The codons under positive selection between GAS6 and
PROS1 were retrieved from the Selectome database of precom-
puted tests of positive selection [62,63], which uses the branch-
site model from CODEML/PAML. In Selectome, we focused
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Figure 1. Phylogenetic consensus tree with and without molecular clock of GAS6, PROS1 and SHBG sequences. (a) Tree without a molecular clock model. The GAS6
clade is coloured in red, the PROS1 clade is in blue and the SHBG clade is in green. Values at the nodes indicate posterior probabilities. Only values different from
1.00 are indicated. The lengths of the axes are proportional to the estimated number of mutations per site. (b) Phylogenetic tree under a relaxed clock model. The
tree topology is the same as that of the tree in panel (a). The estimated times of divergence of the more important nodes are indicated in electronic supplementary
material, table S1. The blue error bars at the nodes represent the 95% confidence limits.
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solely on the branch named ‘Euteleostomi’ (which corresponds
roughly to the basis of vertebrates, as sharks and sea lampreys
are not present in Selectome), which separated the paralogous
genes PROS1 and GAS6.
3.5. Stability effect
The contribution of residues to the SHBG-domain stability
was computed by FOLDX [64], using the function ‘build
Table 1. Sites identified to be under functional divergence between GAS6 and PROS1. Functional divergence analysis was performed using three different
methods: FUNDI (FD) [59], BADASP (B) [57] and Selectome (PS) [62,63]. BADASP is a package to detect both Type I and Type II of functional divergence. Type I
sites are divided into Ia (amino acid conserved in PROS1 and divergent in GAS6) or Ib (amino acid conserved in GAS6 and divergent in PROS1). FUNDI aims to
detect sites under functional divergence, independent of whether they belong to Type I or Type II of functional divergence. For GAS6, numbering is based on
isoform 1 or 2 (between brackets). Overall, the methionine encoded by the translation initiation site is numbered as residue 1.
GAS6 AA PROS1 AA methods GAS6 AA PROS1 AA methods
37 (37) E 31 Q B_Ib 384 (341) Q 345 D B_Ia
51 (51) Q 44 S PS 405 (362) N 366 E B_Ia, B_Ib
60 (60) H 53 N B_II 415 (372) P 376 D B_II, PS
97 (97) N 90 R B_Ia, B_Ib 423 (380) Q 384 N B_Ib
98 (98) K 91 S B_Ia, B_II 432 (389) R 393 H FD, B_Ib
100 (100) G 93 Q B_II 435 (392) V 396 S FD, B_II, PS
102 (102) P 103 S B_Ia 445 (402) K 406 D B_Ib
105 (105) K 106 A B_Ib, B_II 448 (405) V 409 K FD, B_Ib
106 (106) N 107 Y B_Ib 455 (412) P 416 P B_Ia
110 (110) A 111 R FD, B_Ia, B_II 456 (413) E 417 E B_Ib
114 (114) Q 115 N B_Ia 457 (414) R 418 N B_Ia
123 (123) N 124 L B_Ia, B_Ib 463 (420) N 424 K B_II
134 (134) Q 135 K B_Ib 465 (422) T 426 Y FD
136 (136) L 137 G FD 471 (428) F 432 R FD, B_Ia, B_Ib, B_II
141 (141) F 142 T FD 473 (430) E 434 V B_II
143 (143) L 144 T B_Ia 496 (453) G 458 Q FD, B_II
146 (146) A 147 P B_Ia 497 (454) E 459 G B_II
161 (161) S 162 K B_Ib 498 (455) D 460 A B_II
162 (162) Q 163 D FD 508 (465) N 470 K B_II
170 (170) I 174 I B_Ib 510 (467) R 472 N B_Ia, B_Ib, B_II
189 (189) S 193 L B_Ia 512 (469) Q 474 H B_Ib, B_II
192 (192) G 196 K B_Ia 517 (474) T 479 V FD
203 (203) D 207 L B_II 518 (475) E 480 E FD, B_Ia
204 (204) S 209 P B_Ib 526 (483) S 488 S B_Ia
218 (218) S 223 D B_Ib 585 (542) Y 542 S B_Ib, B_II
222 (222) L 227 E B_II 586 (543) H 543 T FD, B_Ia, B_Ib
224 (224) D 229 P B_Ia, B_Ib 588 (545) T 545 E B_Ia, B_Ib
248 (248) E 253 A B_II 593 (550) K 547 S B_Ib
266 (266) G 271 K B_Ia, B_Ib, B_II 595 (552) L 549 D B_Ia, B_Ib, B_II
274 (274) M 279 Q FD 614 (571) D 569 S B_Ib
322 (279) D 284 V B_Ib 618 (575) H 573 S FD, B_Ib
332 (289) A 294 D B_Ia, B_Ib 623 (580) S 578 R FD, B_Ib
337 (294) S 299 L B_II 626 (583) D 581 R B_Ia
343 (300) M 305 Q PS 639 (596) Q 594 T FD
351 (308) R 312 Y B_II, PS 640 (597) S 595 I B_Ib
356 (313) R 317 L B_II 641 (598) E 596 S FD, B_Ib
357 (314) L 318 P B_Ia, B_Ib, PS 657 (614) H 610 A B_Ia, B_II, PS
381 (338) G 342 E B_II 703 (660) Y 656 S FD, B_Ia, B_Ib
383 (340) H 344 I FD, B_Ia, B_Ib 717 (674) E 670 W B_Ib
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model’. We choose the crystallized SHBG domain of GAS6
(PDB ID: 2C5D) because it is the main domain of the protein
and the one participating in interaction. Each amino acid
has been mutated to itself to estimate its contribution to the
energy of the wild-type (DGwt, in kcal mol21). Second, each
amino acid is mutated to all the other 19 amino acids, to cal-
culate the energy of the mutant (DGmut, in kcal mol21).
Therefore, the difference between DGwt and DGmut was
calculated to give the value for DDG (¼DGmut2 DGwt), the
stability effect of replacement of one amino acid for another.
The final result was a substitution matrix for all the amino
acid positions in the GAS6 protein structure.
3.6. Electrostatic surface analysis
The human structures of GAS6 and PROS1 were modelled by
homology using MODELLER [65]. The template used was the
SHBG-domain of GAS6 (PDB ID: 2C5D). We decided to
model theGAS6 over its crystallized structure, in order to facili-
tate the direct comparison with the model of PROS1. The
electrostatic surfaces were computed using APBS (Adaptive
Poisson–Boltzmann Solver), a suite for performing Poisson–
Boltzmann electrostatic calculations on biomolecules [66] and
visualized in PYMOL [67].
3.7. Prediction of protein–protein interactions
GAS6 residues (PDB ID: 2C5D) involved in protein–protein
interactions were predicted with the OPTIMAL DOCKING AREA
(ODA) program from the ICM Pro package (Molsoft) [68].
4. Results and discussion
4.1. Data collection
Representative sequences were collected using BlastP searches
of SHBG, PROS1 and GAS6 amino acid sequences against
the UniProtKB/Swiss-Prot database (www.uniprot.org).
These sequences were aligned with MAFFT [52]. Within each
PROS1, GAS6 or SHBG clade, the sequences share between
100 and 50% pairwise identical residues, respectively. How-
ever, only approximately 40% identical residues were found
between the two clades of, respectively, GAS6 and PROS1
sequences, and sequences of the SHBG clade share only
between 22 and 28% of residues with sequences of the GAS6
and PROS1 clades, respectively.
4.2. Phylogenetic analysis
Phylogenetic inference using NJ, ML and Bayesian analysis
resulted in three almost identical and very robust trees
(with high confidence score per node). The phylogenetic
tree clearly showed three separate clades representing the
SHBG, the PROS1 and the GAS6 clusters (figure 1). Although
unrooted, it is clear that the SHBG clade may serve as an out-
group to the other two clades present in the tree. The tree
topology within the PROS1 and GAS6 clusters was identical.
The evolution of the three genes can be explained by two
rounds of whole-genome duplications (proposed by Ohno
[69] and reviewed in [47] and [70]), where the first event of
duplication of an ancestral gene led to the formation of the
SHBG gene and the ancestor of PROS1/GAS6 genes, while
a second and later duplication event resulted in the formation
of separate PROS1 and GAS6 genes. The similarity of the
branching order within the latter two clades represents the
events of speciation that took place during vertebrates’ evol-
ution. To obtain further information about the time scale at
which the various events took place, a relaxed clock model
was applied using the MRBAYES program. First, using the esti-
mated dates for the divergence of various taxa available in
the TimeTree database (figure 1; electronic supplementary
material, table S1) [56], the median clock rate was estimated
to be 0.00136 amino acid substitutions per site per million
years (figure 1; electronic supplementary material, table S1).
Using this rate, the evolutionary times of the two duplication
events were calculated to be 697 million years ago (Ma) for
SHBG/PROS þ GAS6 and 649 Ma for PROS/GAS6 (figure 1;
electronic supplementary material, table S1). These values are
in line with the evolution of vertebrates, as the split between
vertebrates and the urochordate Ciona is estimated around
700–800 Ma, according to TimeTree.
4.3. Structural impact of the mutations
The replacement of one amino acid by another may have an
effect on protein structure, depending on the position and
physico-chemical properties of the substitution. Some changes
can be very drastic; for example, the replacement of a hydro-
phobic residue such as alanine with a charged residue such
as glutamic acid within the core of a protein structure is
likely to have major consequences for the local and overall
packing of amino acid residues. In the case of a functional
divergence between proteins, it has been hypothesized that
amino acid replacements tend to bemore divergent (stabilizing
or destabilizing) compared with amino acids evolving under a
neutral process, where the function is preserved [71]. This has
previously been observed in a dataset of 22 different enzymes
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Figure 2. Comparison of the stability effect between sites under functional
divergence and other sites. The x-axis represents the categories of sites
detected by FUNDI, BADASP or Selectome. The y-axis represents the absolute
median difference in stability effect (DDG, expressed in kcal mol21)
between the group of amino acids in PROS1 versus the group of amino
acids in GAS6. These values were estimated with FOLDX based on the structure
of GAS6 (PDB ID: 2C5D) [22]. Values above 0.5 kcal mol21 are slightly desta-
bilizing, above 1 kcal mol21 are destabilizing and above 2 kcal mol21 are
strongly destabilizing.
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[72], as well as in ribulose-1,5-bisphosphate carboxylase/
oxygenase (RubisCO) [73] and in cetacean myoglobins [74].
To estimate the effect of an amino acid replacement, we
first calculated the effect on protein stability (DDG, in
kcal mol21) for all residue replacements in the GAS6 struc-
ture (PDB ID: 2C5D [22]). Each residue was mutated in
silico to all 19 other amino acids and the DDG was recorded.
We calculated the composition of amino acids in each column
of the MSA, and using this we defined the contribution of
each amino acid for each sequence to the protein structure
stability. Using the matrix thus generated, we estimated the
median DDG (in kcal mol21) for each column of GAS6 and
for each column of PROS1. Then, we computed the difference
in stability (in absolute value) between GAS6 and PROS1.
The mean and median of all the 391 differences were 0.68
and 0.15 kcal mol21, respectively. We then separated these
positions between sites under functional divergence and
sites not under functional divergence (figure 2). The mean
of non-divergent sites was 0.56 kcal mol21, while the mean
of divergent sites was 1.45 kcal mol21. Similarly, the
median of non-divergent sites was 0.08 kcal mol21, while
the median of divergent sites was 0.60 kcal mol21. The differ-
ence between sites under functional divergence and sites not
under functional divergence was significant (Wilcoxon
signed-rank test, p-value ¼ 1.932 " 1028). This would support
the above-mentioned hypothesis that sites under functional
divergence have a greater effect on the protein structure than
sites not detected to be under functional divergence.
4.4. Three-dimensional visualization
4.4.1. General
We used the crystallized structural complex of Gas6–Axl
(PDB ID: 2C5D [22]) and a homology-based structure for
PROS1 to visualize the location of sites under functional
divergence (figures 3–5). Residual numbering for GAS6 is
based on isoform 1 or 2 (between brackets). We followed
the Human Gene Variation Society (HGVS) numbering
where the methionine encoded by the translation initiation
site is numbered as residue 1 [75].
4.5. Residues close to Axl
Ninesitesunder functionaldivergencewerepresentat the interface
with Axl: Met343(300), Arg351(308), Arg356(313), Leu357(314),
Val435(392), Arg445(402), Arg457(414), Asp498(455) and
Asn508(465) (figure 4). Only residue Met343 was detected by
Selectome as being under positive selection. The methionine
in GAS6 was replaced by a glutamine in PROS1. Val435 and
Arg457 are very closely located in the three-dimensional struc-
ture, andArg457 directly in contact with Axl. The hydrophobic
Val435 is mutated into a polar Ser396 in PROS1, and a polar
positively charged Arg457 is mutated into polar uncharged
Asn418, except in rodents, where there is an aspartate (another
negatively charged amino acid). Asp498 and Asn508 are on
both sides of the helix.
Figure 3. Global view of all sites on PROS1. This is a composite model of the whole PROS1 using different templates. The modelling has been done with YASARAWhat If.
Colouring is domain specific: GLA (cyan), TSR (light yellow), EGF1 (dark blue), EGF2 (red), EGF3 (slate), EGF4 (mangenta), LG1 (yellow) and LG2 (orange).
Figure 4. Three-dimensional visualization of GAS6 in complex with Axl (PDB ID: 2C5D). Sites under functional divergence are shown as spheres and coloured in
orange. Sites under functional divergence and in contact with Axl (in cartoon and in white) are in yellow. a-helices and b-sheets of GAS6 domain are in blue.
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4.6. Residues that have been reported to be involved
in binding of PROS1 to C4BPb
Four sites under functional divergence are present at the
interface (less than 6 A˚) with C4BPb: Lys470, Asn472,
His474 and Ser488. In the three-dimensional structure of
PROS1 Lys470, Asn472 and His474 are sequentially clustered
on LG1, whereas Ser488 is situated on LG2 mirrored to
Asn472 at an estimated distance of 9.2 A˚. The basic residues
Lys470 and His474 are mutated to the polar residues
Asn508(465) and Glu512(469) in GAS6, respectively. The
polar Asn472 is mutated to the basic Arg510(467).
4.7. Residues that have been reported to be involved
in binding of PROS1 to FVa
One site (residue 670) under functional divergence is present
at the binding site for FVa [35]. The hydrophobic residue
Trp670 in PROS1 is mutated to the charged acidic residue
Glu717(673) in GAS6.
4.8. Residues close (less than 6 A˚) to N-acetyl-D-
glucosamine
GAS6 and PROS1 are both post-translationally modified
throughN-linked glycosylation, but at different amino acid pos-
itions. N-linked glycosylation occurs at the attachment site (or
sequon), whose consensus sequence is Asn-X-Ser/Thr
(N-X-S/T), where the N-glycans are covalently attached to the
protein at an asparagine (Asn) residue.N-glycans typically con-
tain three mannose residues and two N-acetylglucosamine
(NAG) residues,whereNAG is directly linked to the asparagine
side chain.
In GAS6, N-glycosylation occurs at one residue in the first
Laminin G-like domain (LG1), at asparagine Asn463(420),
which is on a b-strand in the core of the structure (figure 5).
This asparagine is detected to be under Type II of functional
divergence (replaced by a lysine in PROS1). The residue at pos-
ition n þ 2 is a threonine, which is also under Type II of
functional divergence (replaced by a tyrosine in PROS1).
These two changes break the N-X-S/T motif and prevent N-
glycosylation at this sequon. Two other sites in contact (less
than 6 A˚) with NAGwere also detected to be under functional
divergence: Arg351(308) and Gly381(338). They are on differ-
ent b-strands and replaced by a tyrosine and a glutamic acid
in PROS1, respectively. Similarly, some residues, which are
part of the pocket where NAG is located, are under functional
divergence. For example, Thr465(422) is in the sameb-strand as
Asn463(420). Gln384(341) is in close contact with Phe471(428),
which precedesHis429. Gln384(341) is replaced byan aspartate
in PROS1 and Phe471(428) by a lysine.
In PROS1, N-glycosylations occur at three asparagine
residues (Asn499, Asn509 and Asn530) in the second Laminin
G-like domain (LG2). These three residues were not detected
to be under functional divergence, but they were also different
in GAS6, where they were replaced by Arg537 and Glu551.
Asn530 is an insertion in PROS1 primates. The region around
Asn530 is very divergent and none of the residues
around Asn530 in PROS1 were found to be functionally diver-
gent. However, residues Arg578, Arg581 and Ala610, which
are in close three-dimensional proximity (8 A˚) to the NAG
binding sites Asn499, Asn509 and Asn530, respectively, were
found to be functionally divergent. In GAS6, these residues
were replaced by Ser623(580), Asp626(583) and His657(614),
respectively (electronic supplementary material, figure S1).
4.9. Comparison of electrostatic surfaces between
PROS1 and GAS6
Using APBS [66] to compute the electrostatic properties of the
surfaces of the SHBG domain, we observed three patches that
are different between PROS1 and GAS6 (figure 6).
The first patch showed a strong basic patch in GAS6
(in blue), formed by residues Ala332(289), Lys333(290),
Lys336(293), Lys506(463), Arg510(467) and Arg684(641),
Figure 5. Visualization of N-acetylglucosamine (NAG) binding site. The asparagine at position Asn463(420) in GAS6 is mutated to a lysine in PROS1. NAG ligand is in
stick and coloured in yellow. Sites under functional divergence are coloured in orange. a-helices and b-sheets of GAS6 domain are in blue. Axl domains are in grey.
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while in PROS1, the corresponding residues were either polar
or acidic (Asp294, Thr295, Glu298, Gln468, Asn472 and
Asn637). Residues Ala332(289) and Arg510(467) in GAS6
and residues Asp294 and Asn472 in PROS1 have been
detected to be under functional divergence. On this patch
residues Gln468 and Asn472 were located in the binding
site of C4BPb.
The second patch is more acidic in GAS6, formed
by Arg537(494), Ser623(580), Asp626(583), Glu628(585),
Gln648(605), Glu649(606), Arg656(613) and Arg659(616),
while more basic in PROS1 (Asn499, Arg578, Arg581,
Asn583, Gln601, Arg602, Lys609 and Lys612). Residues
Ser623(580) and Asp626(583) in GAS6 and residues Arg578
and Arg581 in PROS1 on this patch were detected to be
under functional divergence. Asp499 in PROS1, attached to
NAG, is located at the binding site of C4BPb.
The third patch is basic in GAS6 formed by Arg403(380),
Asn405(362), Ala431(388), Arg432(389), Lys445(402) and
Ala447(404), while it is an acidic patch in PROS1 formed by
Lys364, Glu366, Glu392, His393, Asp406 and Asn408. Resi-
dues Asn405(362), Arg432(389) and Lys445(402) in GAS6
and residues Glu366 and Asp406 in PROS1 were detected
to be under functional divergence. This patch is at the contact
interface between GAS6 and Axl.
4.10. Protein–protein interaction prediction
We used the ODA analysis [68] to identify residues that may
be responsible for protein–protein interactions. ODA works
essentially for protein–protein interaction predictions that
involve large hydrophobic patches. ODA identifies optimal
surface patches with the lowest docking desolvation energy
values as calculated by atomic solvation parameters (ASP)
derived from octanol/water transfer experiments and
adjusted for protein–protein docking. Using the ODA analy-
sis, we identified residues that may be responsible for
protein–protein interactions (figure 7).
We observed a striking difference between the two proteins
and a clear shift in the predicted protein–protein interaction
areas between the two proteins. Note that these residues are
present in the LG2 domain of both proteins. Three distinct
regions within the LG2 domain of PROS1 have been identified
to interact with C4BP (488–501 and 646–655) [25–27,31,32]
and FVa (662–676) [35]. No residues were located in one of
these three regions. For GAS6, the interactions with Axl in
the 2C5D structure appear exclusively mediated through LG1
[22]. Potentially, the predicted residues of GAS6 mediate con-
tact to other receptors such as Mer or Tyro3, all of which
have been shown to interact with GAS6. However, among
the identified residues within the LG2 domain of GAS6,
Phe528 is suggested to have a controlling function in GAS6–
Axl interactions [22]. None of the predicted residues was
predicted to be under functional divergence.
5. Conclusion
GAS6 and PROS1 have been widely studied for their bio-
logical functions. Despite their homology and structural
resemblances, both proteins exhibit distinct functions. In
PROS1 GAS6
Figure 6. Visualization of electrostatic surfaces on the SHBG-domain of PROS1 and GAS6. To make the direct comparison between GAS6 and PROS1 easier, we have
modelled their SHBG domains using the GAS6 PDB structure (PDB ID: 2C5D). NAG ligand has been added to identify its putative binding pocket. While it is crystal-
lized in GAS6, there is no evidence to indicate whether it can be present in PROS1. Basic surfaces are in blue while acidic surfaces are in red. The NAG ligand is in
green. The green circles indicate the observed differences in electrostatic surface potential between GAS6 and PROS1.
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this study, we investigated the evolutionary trajectory of the
paralogous genes GAS6 and PROS1 to better understand
how these two genes became functionally different. Our
results indicate that these genes emerged at the beginning
of vertebrate evolution, which is estimated at 550–700 Ma,
since the last split with urochordates (like the tunicate Ciona
intestinalis). This also corresponds to the time when the two
rounds of whole-genome duplication occurred in vertebrates.
Additionally, we identified residues under functional diver-
gence in the two proteins encoded by GAS6 and PROS1.
These residues were scattered throughout the two genes.
However, approximately 60% of all residues under functional
divergence were located in the SHBG domain (LG1/LG2) in
both the proteins. GAS6 and PROS1 require this domain for
their distinct functions. Only a small fraction of functionally
divergent residues were located in the binding site. We also
determined the implications of the sites under functional diver-
gence on the structures of GAS6 and PROS1. From these
data, we conclude that the sites under functional divergence
are predominantly required for the overall structure and func-
tion of both proteins. We identified functionally important
sites, which will help in understanding the molecular basis of
the functional divergence between both these genes as well
as providing significant information about species-specific
adaptation. Finally, these resultsmight help researchers to ana-
lyse disease-causing mutations in the light of evolution and
structural constraints.
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Figure 7. Optimal docking area analysis for LG1 and LG2-domains of GAS6 and PROS1. Red dots indicate likely interaction areas, blue indicates protein–protein
interactions to be unlikely. (a) For GAS6, the most likely interactions are with F528, F530, L663, P670 and D671. (b) For PROS1, the most likely interactions are with
Y484, T518, T520, Q548 and A634.
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